Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

$12.6b gold deal; China launches missile in the Pacific; SBS wins at FIFA World Cup
16:51

Q+A: The bet that transformed investing in Australia
11:21

Afternoon Report | Miners, banks sold off
04:41